Full Text View
Tabular View
No Study Results Posted
Related Studies
Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer
This study is currently recruiting participants.
Verified February 2013 by Memorial Sloan-Kettering Cancer Center
Study NCT01502592   Information provided by Memorial Sloan-Kettering Cancer Center

First Received on December 29, 2011.   Last Updated on February 28, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Additional conditions recognized in this trial
Adenocarcinoma
Adenocarcinoma, Mucinous
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Carcinoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Cystic, Mucinous, and Serous
Neoplasms, Glandular and Epithelial
Skin Diseases
Interventions listed in this trial
Cryoablation
Ipilimumab
Sponsors listed in this trial
Memorial Sloan-Kettering Cancer Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services